Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Ribi's melanoma vaccine accepted for fast-track review in Canada

Sep. 29, 1997

Betathine available for licensing from Dovetail

Sep. 29, 1997

Novopharm Biotech seeks approval for melanoma vaccine trial

Sep. 17, 1997

PDL grants antibody humanization patent license to NeoRx

Sep. 17, 1997

Biomira reports phase II results for cancer vaccine

Sep. 15, 1997

New clinical study on Multikine initiated in Canada

Sep. 12, 1997

Regressin induces apoptosis and direct inhibition of tumor cell growth

Sep. 12, 1997

Safety study of Multikine in prostate cancer patients completed

Sep. 10, 1997

Ribi seeks approval for melanoma vaccine in Canada

Sep. 9, 1997

Vical's Allovectin-7 enters phase II for head and neck cancer

Sep. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...